首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats.
【24h】

Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats.

机译:慢性肾内或静脉输注去甲肾上腺素诱发清醒大鼠高血压的血流动力学特征。

获取原文
           

摘要

The present study was designed to determine the hemodynamic changes underlying the hypertension induced by chronic intrarenal infusion of norepinephrine (NE) in conscious rats. NE was infused for a 5-day period intrarenally with osmotic minipumps via a chronic catheter in the right suprarenal artery at rates of 4 and 36 micrograms . kg-1 . hr-1 or intravenously at a rate of 36 micrograms . kg-1 . hr-1. Control rats received a 1 microliter . hr-1 intrarenal infusion of pyrogen-free 0.9% NaCl. In separate experiments, short-term effects were measured continuously during a 22- to 24-hour intrarenal infusion of 4 and 36 micrograms NE . kg-1 . hr-1 or intravenous infusion of 36 micrograms NE . kg-1 . hr-1. Intrarenal infusion of NE produced a more pronounced long-term hypertensive effect than infusion of the same dose intravenously. This hypertension was characterized by a rapid and sustained increase in total peripheral resistance index (TPRI). Despite of the initial renal vasoconstriction, specifically produced during the first 24 hours of intrarenal NE application, cardiac index (CI) in parallel to stroke volume index (SVI) decreased significantly during intrarenal as well as during intravenous NE infusion. Furthermore, no signs of sodium retention were observed. Both rates of intrarenal NE infusion have been shown previously to produce a significant long-term increase in plasma potassium concentration, and the present study indicates that this is presumably the result of decreased urinary potassium output. It is concluded that chronic hypertension produced by intrarenal or intravenous infusion is not volume-dependent. The relatively greater increase in TPRI during intrarenal NE infusion is attributed to vascular wall receptor sensitization by increased plasma potassium levels resulting from effects of intrarenally present NE on tubular cation exchange mechanisms.
机译:本研究旨在确定意识大鼠慢性肾内注射去甲肾上腺素(NE)诱发高血压所致的血液动力学变化。通过右肾上动脉的慢性导管在肾内向NE注入渗透性微型泵5天,速率为4和36微克。千克-1。 hr-1或以36微克的速度静脉注射。千克-1。 hr-1。对照大鼠接受1微升。 hr-1肾内输注无热原的0.9%NaCl。在单独的实验中,在22到24小时肾内输注4和36微克NE的过程中连续测量了短期效果。千克-1。 hr-1或36毫克NE静脉滴注。千克-1。 hr-1。肾内输注NE产生的长期高血压效果比静脉内输注相同剂量的肾病更为明显。该高血压的特征在于总外周阻力指数(TPRI)的持续快速增加。尽管最初出现肾脏血管收缩,特别是在肾内应用NE的最初24小时内产生,但在肾内以及静脉内NE输注期间,与卒中体积指数(SVI)平行的心脏指数(CI)明显降低。此外,未观察到钠保留的迹象。先前已显示两种肾内NE输注速率均可长期显着增加血浆钾浓度,本研究表明这可能是尿钾输出减少的结果。结论是,肾内或静脉内输注所产生的慢性高血压不是体积依赖性的。肾内NE输注期间TPRI相对较大的增加归因于肾内存在的NE对肾小管阳离子交换机制的影响,血浆钾水平升高导致血管壁受体敏化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号